The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Aug. 01, 2017

Filed:

Dec. 18, 2014
Applicant:

Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.l.a. China, Beijing, CN;

Inventors:

Wu Zhong, Beijing, CN;

Song Li, Beijing, CN;

Yanqun Zeng, Beijing, CN;

Junhai Xiao, Beijing, CN;

Xinbo Zhou, Beijing, CN;

Zhibing Zheng, Beijing, CN;

Xingzhou Li, Beijing, CN;

Xiaokui Wang, Beijing, CN;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/155 (2006.01); A61K 31/17 (2006.01); C07C 335/04 (2006.01); C07C 391/00 (2006.01); C07D 213/75 (2006.01); C07C 335/08 (2006.01); C07C 335/14 (2006.01); C07C 335/16 (2006.01); C07C 335/18 (2006.01); C07D 295/16 (2006.01); C07C 335/20 (2006.01); C07D 211/06 (2006.01);
U.S. Cl.
CPC ...
C07C 391/00 (2013.01); C07C 335/08 (2013.01); C07C 335/14 (2013.01); C07C 335/16 (2013.01); C07C 335/18 (2013.01); C07C 335/20 (2013.01); C07D 211/06 (2013.01); C07D 213/75 (2013.01); C07D 295/16 (2013.01); C07C 2101/02 (2013.01); C07C 2101/14 (2013.01); C07C 2101/16 (2013.01);
Abstract

The invention provides a compound of Formula I, an isomer, a pharmaceutically acceptable salt, or a solvate thereof, and use thereof in manufacture of a medicament for preventing and/or treating a drug-resistant tumor or disease or disorder caused by a drug-resistant bacterium, or use thereof in manufacture of a medicament for preventing and/or treating a tumor, a neurodegenerative disease, an allogeneic graft rejection, or an infection-associated disease or disorder; preferably, the tumor, neurodegenerative disease, allogeneic graft rejection, or infection-associated disease or disorder is a disease or disorder caused by Heat shock protein 70 (Hsp70). The compounds of the invention, which are a class of Hsp70 inhibitors having a novel structure and a high activity, solve the problem concerning drug resistance of tumors, enhance the effect of treating tumors, and provide a new medical strategy for treatment of tumors in clinic.


Find Patent Forward Citations

Loading…